Should we screen for coeliac disease? Yes or No

BMJ (Online)

Volumn 339, Issue 7728, 2009, Pages 998-999

  Fasano, Alessio ^a   Evans, Kate E ^b   McAllister, Ruth ^b   Sanders, David S ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTEN; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ANEMIA; AUTOIMMUNITY; AWARENESS; CELIAC DISEASE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIET THERAPY; DOWN SYNDROME; EARLY DIAGNOSIS; GENETIC SUSCEPTIBILITY; GLUTEN FREE DIET; HASHIMOTO DISEASE; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; IMMUNE RESPONSE; INCIDENCE; INFERTILITY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOMA; MASS SCREENING; MORBIDITY; NOTE; OSTEOPOROSIS; PRIORITY JOURNAL; PUBLIC HEALTH; QUALITY OF LIFE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEROLOGY; TREATMENT INDICATION; ARTICLE; COST BENEFIT ANALYSIS; ECONOMICS;

CELIAC DISEASE; COST-BENEFIT ANALYSIS; EARLY DIAGNOSIS; HEALTH POLICY; HUMANS; MASS SCREENING;

EID: 70350558700     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b3592     Document Type: Note

References (0)